AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Mar 29, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2004.057828v1
96/5/770    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wood, E.
Right arrow Articles by Tyndall, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wood, E.
Right arrow Articles by Tyndall, M. W.
©
American Journal of Public Health, 10.2105/AJPH.2004.057828


Field Action Reports

Service Uptake and Characteristics of Injection Drug Users Utilizing North America's First Medically Supervised Safer Injecting Facility

Evan Wood 1*, Thomas Kerr 1, Zhenguo Qui 1, Ruth Zhang 2, Julio S.G. Montaner 1, Mark W. Tyndall 1

1 University of British Columbia
2 Univeristy of British Columbia

* To whom correspondence should be addressed. E-mail: ewood{at}cfenet.ubc.ca.


   Abstract

In 2003, the city of Vancouver, British Columbia, opened North America's first government-sanctioned safer injecting facility, where injection drug users (IDUs) can inject preobtained illicit drugs under the supervision of nurses. Use of the service by IDUs was followed by measurable reductions in public drug use and syringe sharing. IDUs who are frequently using the program tend to be high-intensity cocaine and heroin injectors and homeless individuals.

The facility has provided high-risk IDUs a hygienic space where syringe sharing can be eliminated and the risk of fatal overdose reduced. Ongoing evaluation will be required to assess its impact on overdose rates and HIV infection levels, as well as its ability to improve IDU contact with medical care and addiction treatment

Key Words: Access to Care, HIV/AIDS, Homelessness, Human Rights, Hepatitis, Drugs




This article has been cited by other articles:


Home page
Am. J. Public HealthHome page
L. Beletsky, C. S. Davis, E. Anderson, and S. Burris
The Law (and Politics) of Safe Injection Facilities in the United States
Am J Public Health, February 1, 2008; 98(2): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
E. Wood, M. W. Tyndall, J. S. Montaner, and T. Kerr
Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
Can. Med. Assoc. J., November 21, 2006; 175(11): 1399 - 1404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Public Health Association